Skip to main content
Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc. — Investor Relations & Filings

Ticker · ORGO ISIN · US68621F1021 LEI · 549300RLC2O821TU6941 US Manufacturing
Filings indexed 651 across all filing types
Latest filing 2026-04-30 Proxy Solicitation & In…
Country US United States of America
Listing US ORGO

About Organogenesis Holdings Inc.

https://investors.organogenesis.com

Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacturing, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company provides a portfolio of bioactive and acellular biomaterials products that are designed to empower healing and restore function for patients. Its core activities involve creating innovative tissue-based therapies to address unmet medical needs in various clinical settings.

Recent filings

Filing Released Lang Actions
DEF 14A - Organogenesis Holdings Inc. (0001661181) (Filer)
Proxy Solicitation & Information Statement
2026-04-30 English
4 - ORGANOGENESIS HOLDINGS INC. (0001661181) (Filer)
Director's Dealing
2026-03-03 English
10-K - ORGANOGENESIS HOLDINGS INC. (0001661181) (Filer)
Annual Report FY 2025
2026-02-26 English
8-K - ORGANOGENESIS HOLDINGS INC. (0001661181) (Filer)
Regulatory Filings
2026-02-26 English
8-K - ORGANOGENESIS HOLDINGS INC. (0001661181) (Filer)
Regulatory Filings
2026-02-23 English
4 - ORGANOGENESIS HOLDINGS INC. (0001661181) (Filer)
Director's Dealing
2026-02-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.